David Anstice
Präsident bei Banyu Pharmaceutical Co. Ltd.
Aktive Positionen von David Anstice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Banyu Pharmaceutical Co. Ltd.
 Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 03.02.2011 | - |
| Präsident | 01.10.2007 | - | |
| The University of Sydney USA Foundation | Direktor/Vorstandsmitglied | - | - |
| Vorsitzender | - | - | |
| Präsident | - | - | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 16.09.2011 | - |
| Independent Dir/Board Member | 16.09.2011 | - | |
| Us Foundation of The University of The Valley of Guatemala | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
NeuClone Pty Ltd.
 NeuClone Pty Ltd. BiotechnologyHealth Technology NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia. | Direktor/Vorstandsmitglied | - | - |
| United States Studies Centre | Direktor/Vorstandsmitglied | - | - |
Neuclone Pharmaceuticals Pty Ltd.
 Neuclone Pharmaceuticals Pty Ltd. BiotechnologyHealth Technology Neuclone Pharmaceuticals Pty Ltd. manufactures biological products. The private company is based in Sydney, Australia. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Anstice
Ehemalige bekannte Positionen von David Anstice
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALKERMES PLC | Direktor/Vorstandsmitglied | 01.10.2008 | 07.07.2022 |
| Independent Dir/Board Member | 01.09.2011 | 07.07.2022 | |
| CSL LIMITED | Direktor/Vorstandsmitglied | 26.06.2009 | 17.10.2018 |
| Independent Dir/Board Member | 02.09.2008 | 17.10.2018 | |
| ░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von David Anstice
| The University of Sydney | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Australien | 6 |
| Japan | 2 |
Operativ
| Director/Board Member | 10 |
| President | 3 |
| Independent Dir/Board Member | 3 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CSL LIMITED | Health Technology |
| ALKERMES PLC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Banyu Pharmaceutical Co. Ltd.
Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | Health Technology |
| The University of Sydney USA Foundation | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
| Us Foundation of The University of The Valley of Guatemala | |
NeuClone Pty Ltd.
NeuClone Pty Ltd. BiotechnologyHealth Technology NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia. | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Neuclone Pharmaceuticals Pty Ltd.
Neuclone Pharmaceuticals Pty Ltd. BiotechnologyHealth Technology Neuclone Pharmaceuticals Pty Ltd. manufactures biological products. The private company is based in Sydney, Australia. | Health Technology |
- Börse
- Insiders
- David Anstice
- Erfahrung
